Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
暂无分享,去创建一个
Aung Ko Win | J. Potter | G. Giles | J. Hopper | S. Thibodeau | A. Antoniou | L. Le Marchand | G. Casey | J. Dowty | Andrew Lee | P. Newcomb | Yingye Zheng | D. Ahnen | S. Gallinger | N. Lindor | C. Rosty | D. Buchanan | M. Clendenning | R. Haile | R. MacInnis | M. Jenkins
[1] P. Broderick,et al. Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer , 2016, Nature Communications.
[2] Aung Ko Win,et al. Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. , 2016, Future oncology.
[3] S. Letovsky,et al. Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification , 2015, Genetics in Medicine.
[4] J. Hopper,et al. The Heritability of Prostate Cancer—Letter , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[5] K. Smith,et al. Familial colorectal cancer risk by subsite of primary cancer: a population‐based study in Utah , 2015, Alimentary pharmacology & therapeutics.
[6] Christopher D. Heinen,et al. Milestones of Lynch syndrome: 1895–2015 , 2015, Nature Reviews Cancer.
[7] Aung Ko Win,et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. , 2014, Gastroenterology.
[8] Rodney J Scott,et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.
[9] I. Coulson,et al. Cowden syndrome (multiple hamartoma syndrome) , 2013, Clinical and experimental dermatology.
[10] Peter Donnelly,et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.
[11] Aung Ko Win,et al. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? , 2013, European journal of cancer.
[12] G. Giles,et al. Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E , 2013, PloS one.
[13] Aung Ko Win,et al. Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers , 2012, Human mutation.
[14] Aung Ko Win,et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Mitchell H Gail,et al. Confirmation of family cancer history reported in a population-based survey. , 2011, Journal of the National Cancer Institute.
[16] Aung Ko Win,et al. Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis , 2011, Familial Cancer.
[17] A. de la Chapelle,et al. The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means? , 2011, Cancer Prevention Research.
[18] O. Dekkers,et al. Survival of MUTYH-Associated Polyposis Patients With Colorectal Cancer and Matched Control Colorectal Cancer Patients , 2010, Journal of the National Cancer Institute.
[19] M. Shike,et al. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.
[20] David P. Taylor,et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. , 2010, Gastroenterology.
[21] Finlay Macrae,et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. , 2010, Journal of the National Cancer Institute.
[22] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[23] J. Knight,et al. Family history of hormonal cancers and colorectal cancer risk: A case‐control study conducted in Ontario , 2009, International journal of cancer.
[24] John L Hopper,et al. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics , 2009, Human mutation.
[25] J. Potter,et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. , 2009, Gastroenterology.
[26] Z. Szentirmay,et al. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome , 2009, Human mutation.
[27] A. Spurdle,et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.
[28] J. Potter,et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.
[29] John D Potter,et al. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[30] A. Rustgi,et al. The genetics of hereditary colon cancer. , 2007, Genes & development.
[31] Jukka-Pekka Mecklin,et al. Explaining the Familial Colorectal Cancer Risk Associated with Mismatch Repair (MMR)-Deficient and MMR-Stable Tumors , 2007, Clinical Cancer Research.
[32] John L Hopper,et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] D. Easton,et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.
[34] D. Bishop,et al. After hMSH2 and hMLH1—what next? Analysis of three‐generational, population‐based, early‐onset colorectal cancer families , 2002, International journal of cancer.
[35] Alison L. Livingston,et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.
[36] J. Terdiman. HNPCC: an uncommon but important diagnosis. , 2001, Gastroenterology.
[37] L. Aaltonen,et al. Population carrier frequency of hMSH2 and hMLH1 mutations , 2000, British Journal of Cancer.
[38] L. Aaltonen,et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] T. Smyrk,et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members , 1998, Cancer.
[40] J. Ferlay,et al. Cancer Incidence in Five Continents , 1997 .
[41] K. Lange,et al. An approximate model of polygenic inheritance. , 1997, Genetics.
[42] L. Aaltonen,et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. , 1996, Gastroenterology.
[43] R. Elston,et al. The finite polygenic mixed model: An alternative formulation for the mixed model of inheritance , 1994, Theoretical and Applied Genetics.
[44] J. Carlin,et al. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. , 1992, American journal of epidemiology.
[45] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[46] Margaret Robertson,et al. Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.
[47] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[48] A J Krush,et al. Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.
[49] H. Akaike. A new look at the statistical model identification , 1974 .
[50] P. Laird,et al. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. , 2011, The Journal of molecular diagnostics : JMD.
[51] S. Thibodeau,et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome , 2009, Genetics in Medicine.
[52] Suet Yi Leung,et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.
[53] A. Chapelle. The Incidence of Lynch Syndrome , 2004, Familial Cancer.
[54] R. C. Elston,et al. Models for Discrimination Between Alternative Modes of Inheritance , 1990 .
[55] Daniel Gianola,et al. Advances in Statistical Methods for Genetic Improvement of Livestock , 1990, Advanced Series in Agricultural Sciences.
[56] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[57] R. Fisher. XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance. , 1919, Transactions of the Royal Society of Edinburgh.
[58] L. Penrose,et al. THE CORRELATION BETWEEN RELATIVES ON THE SUPPOSITION OF MENDELIAN INHERITANCE , 2022 .